p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice

Oncogene
E Landesman-BollagD C Seldin

Abstract

Protein kinase CK2 (casein kinase II) is a serine-threonine protein kinase with many substrates, some of which are involved in cell cycle regulation. CK2 activity is elevated in human solid tumors and leukemia, and dysregulated expression of CK2 induces lymphoma in transgenic mice. Mice that are deficient in p53 also develop lymphomas, and p53 activity may be regulated by CK2 phosphorylation. Here we demonstrate that CK2alpha transgenic mice partially or completely deficient in p53 develop thymic lymphomas at a markedly accelerated rate when compared to p53-deficient mice lacking the transgene. Lymphomas originating from CK2alpha transgenic mice that are heterozygous for p53 generally lose the wild type p53 allele, indicating that loss of p53 is an important step in tumor progression. Moreover, though lymphomas occur as early as 3 weeks of age in the transgenic mice that are nullizygous for p53, they are still monoclonal, indicating that additional stochastic mutations are required for their development. These lymphomas express high levels of myc mRNA and frequently ectopically express Lmo-2, a transcription factor involved in human T cell acute lymphocytic leukemia. The p53-null CK2alpha transgenic lymphomas grow rapidly but a...Continue Reading

Citations

Sep 1, 2005·Apoptosis : an International Journal on Programmed Cell Death·S SeeberB Guerra
Jul 1, 2008·Molecular and Cellular Biochemistry·Alexandre DeshièreOdile Filhol
Jul 14, 2011·Molecular and Cellular Biochemistry·Sinisa DovatZhanjun Li
Oct 16, 2002·Cancer Genetics and Cytogenetics·Masanori DaibataHirokuni Taguchi
Jun 14, 2002·Trends in Cell Biology·Khalil AhmedClaude Cochet
Aug 16, 2008·Molecular BioSystems·Stefania Sarno, Lorenzo A Pinna
Oct 24, 2007·Molecular and Cellular Biology·David Y LouDavid C Seldin
Feb 4, 2009·Molecular and Cellular Biology·Nicole A St-DenisDavid W Litchfield
May 9, 2002·Molecular and Cellular Biology·Imogen M JohnstonRobert J White
Jan 28, 2005·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Mary Ellen K Olsten, David W Litchfield
Apr 8, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew S BrownZhong Chen
Jul 19, 2011·World Journal of Biological Chemistry·Chunhua SongSinisa Dovat
Feb 13, 2001·Biochemical and Biophysical Research Communications·S AllamaneD Wion
Aug 28, 2003·Médecine sciences : M/S·Thierry Buchou, Claude Cochet
Apr 9, 2005·Cell Death and Differentiation·G Di MairaM Ruzzene
Nov 14, 2015·Expert Opinion on Therapeutic Targets·Giorgio Cozza, Lorenzo A Pinna
Sep 26, 2002·FEBS Letters·Susan J MillerBenjamin G Neel
Dec 7, 2000·Cancer Investigation·N DoninJ Leibovici
May 1, 2009·Ecotoxicology and Environmental Safety·Reyna Colli-DuláOmar Zapata-Perez
Jul 30, 2008·Cellular Signalling·Greg VilkDavid W Litchfield
Jan 22, 2005·Annals of the New York Academy of Sciences·Christian BronnerMarc Mousli
Feb 11, 2003·Journal of Cellular Biochemistry·Huamin WangKhalil Ahmed
Nov 30, 2006·Chembiochem : a European Journal of Chemical Biology·Mario A PaganoLorenzo A Pinna
Sep 12, 2007·International Journal of Cancer. Journal International Du Cancer·Yasser PereraSilvio E Perea

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.